HDL content and composition in acute phase response in three species: Triglyceride enrichment of HDL a factor in its decrease

Journal of Lipid Research

Volumn 37, Issue 12, 1996, Pages 2662-2674

  Cabana, Veneracion G ^a   Lukens, John R ^a   Rice, Karen S ^b   Hawkins, Terry J ^b   Getz, Godfrey S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

apoA I; Baboon acute phase response; HDL; HDL choleslerol; Hypertriglyceridemia; Lipoproteins; Mouse acute phase response; Rabbit acute phase response; Serum amyloid A; Triglyceride rich HDL

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACUTE PHASE RESPONSE; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; DENSITY GRADIENT CENTRIFUGATION; DISSOCIATION CONSTANT; DRUG BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DENATURATION; RABBIT; ANIMAL; CHEMISTRY; METABOLISM; MOUSE; PAPIO; SPECIES DIFFERENCE;

ACUTE-PHASE REACTION; ANIMALS; LIPOPROTEINS, HDL; MICE; PAPIO; RABBITS; SPECIES SPECIFICITY; TRIGLYCERIDES;

EID: 0030300182     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Scanu, A. M., V. G. Cabana, and A. Spector. 1986. Lipoprotein disorders: defects of apolipoproteins, enzymes and receptors. In Biochemistry and Biology of Plasma Lipoproteins. A. M. Scanu and A. Spector, editors. Marcel Dekker, Inc., New York, NY, 453.
2. Cabana, V. G., D. A. Shewmon, and A. M. Scanu. 1985. Acute phase response in humans: correlation between plasma levels of C-reactive protein and lipoproteins. Arteriosclerosis. 5: 535a.
3. Blackman, J. D., V. G. Cabana, and T. Mazzone. 1993. The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma. J. Intern. Med. 233: 201-204.
4. Gidding, S., V. G. Cabana, G. S. Getz, A. Rowley, and S. Shulman. 1993. Serum amyloid A, HDL cholesterol and apolipoprotein A-I in Kawasaki disease. Circulation. Suppl. I-88: 0057.
5. Gotto, A. M., Jr. 1990. Interrelationship of triglycerides with lipoproteins and high density lipoproteins. Am. J. Cardiol. 66: 20A-23A.
6. Pepys, M. B., and M. Baltz. 1983. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34: 141-212.
7. Cabana, V. G., H. Gewurz, and J. N. Siegel. 1982. Interaction of very low density lipoproteins with rabbit C-reactive protein. J. Immunol. 128: 2342-2348.
8. Benditt, E. P., and N. Eriksen. 1977. Amyloid SAA is associated with high density lipoprotein for human serum. Proc. Natl. Acad. Sci. USA. 74: 4025-4028.
9. Alvarez, C., and A. Ramos. 1986. Lipids, lipoproteins, and apoproteins in serum during infection. Clin. Chem. 32: 142-145.
10. Sammalkorpi, K., V. Valtonen, Y. Kerttula, E. Nikkila, and M. R. Taskinen. 1988. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 37: 859-865.
11. Salo, E., E. Pesonen, and J. Viikari. 1991. Serum cholesterol levels during and after Kawasaki disease. J. Pediatr. 119: 557-561.
12. Newburger, J. W., J. C. Burns, A. S. Beiser, and J. Loscalzo. 1991. Altered lipid profile after Kawasaki syndrome. Circulation. 84: 625-631.
13. Fahie-Wilson, M., R. Mills, and K. Wilson. 1987. HDL-cholesterol and the acute phase response following myocardial infarction and acute pancreatitis. Clin. Chim. Acta. 167: 197-209.
14. Eriksen, N., and A. P. Benditt. 1984. Trauma, high density lipoproteins, and serum amyloid A. Clin. Chim. Acta. 140: 139-149.
15. Liuzzo, G., L. M. Biasucci, J. R. Gallimore, R. L. Grillo, A. G. Rebuzzi, M. B. Pepys, and A. Maseri. 1994. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N. Engl. J. Med. 331: 417-424.
16. Cabana, V. G., J. N. Siegel, and S. M. Sabesin. 1989. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J. Lipid Res. 30: 39-49.
17. Cabana, V. G., H. Gewurz, and J. N. Siegel. 1983. Inflammation-induced changes in rabbit CRP and plasma lipoproteins. J. Immunol. 130: 1736-1742.
18. Tall, A. R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
19. Schumaker, V. N., and D. L. Puppione. 1986. Sequential flotation ultracentrifugation. Methods Enzymol. 128: 155-170.
20. Bartlett, G. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234: 466-471.
21. Markwell, M. A., S. M. Hass, L. L. Beiber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
22. Albers, J. J., P. W. Wahl, V. G. Cabana, and W. Hazzard. 1975. Quantitation of human plasma apolipoprotein A-I of human plasma high density lipoprotein: relationship to age, sex and lipid levels. Metabolism. 24: 633-644.
23. Weber, K., and M. Osborne. 1969. The reliability of molecular weight determination by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Biol. Chem. 244: 4406-4412.
24. Kashyap, M. L., B. A. Hynd, K. Robinson, and P. S. Gartside. 1981. Abnormal preponderance of sialylated apolipoprotein C-III in triglyceride-rich lipoproteins in type V hyperlipoproteinemia. Metabolism. 30: 111-118.
25. Holbrook, I. B., and A. G. Leaver. 1976. A procedure to increase the sensitivity of staining by Coomassie brilliant blue G250-perchloric acid solution. Anal. Biochem. 75: 634-636.
26. Blanche, P., E. Gong, T. Forte, and A. Nichols. 1981. Characterization of human high density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta. 665: 408-419.
27. Towbin, H., and J. Gordon. 1984. Immunoblotting and dot blotting - current status and outlook. J. Immunol. Methods. 7: 313-340.
28. O'Meara, N. M., V. G. Cabana, J. R. Lukens, B. Loharikar, T. M. Forte, K. S. Polonsky, and G. S. Getz. 1994. Heparin-induced lipolysis in hypertriglyceridemic subjects results in the formation of atypical HDL particles. J. Lipid Res. 35: 2178-2190.
29. Masucci-Magoulas, L., P. Moulin, X. C. Jiang, H. Richardson, A. Walsh, and J. L. Breslow. 1995. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. J. Clin. Invest. 95: 1587-1594.
30. Grunfeld, C., and K. R. Feingold. 1992. Tumor necrosis factor, interleukin, and interferon induced changes in lipid metabolism as part of host defense. Proc. Soc. Exp. Biol. Med. 200: 224-227.
31. Gruber, P. J., A. Torres-Rosado, M. L. Wolak, and T. Leff. 1994. ApoC-III gene transcription is regulated by a cytokine inducible NF-kappa B element. Nucleic Acids Res. 22: 2417-2422.
32. Aalto-Setala, K., E. A. Fisher, A. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) C-III transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apoC-III and reduced apoE on the particles. J. Clin. Invest. 90: 1889-1900.
33. Feingold, K. R., and C. Grunfeld. 1992. Roles of cytokines in inducing hyperlipidemia. [Review]. Diabetes, 41 Suppl. 2: 97-101.
34. Feingold, K. R., M. Marshall, R. Gulli, A. H. Moser, and C. Grunfeld. 1994. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler. Thromb. 14: 1866-1872.
35. Morrone, G., G. Ciliberto, S. Oliviero, R. Arcone, L. Dente, J. Content, and R. Cortese. 1988. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J. Biol. Chem. 263: 12554-12558.
36. Melchior, G. W., C. K. Castle, R. W. Murray, W. L. Blake, D. M. Dinh, and K. R. Marotti. 1994. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 269: 8044-8051.
37. Horowitz, B. S., I. J. Goldberg, J. Merab, T. M. Vanni, R. Ramakrishnan, and H. N. Ginsberg. 1993. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J. Clin. Invest. 91: 1743-1752.
38. Goldberg, I. J., W. S. Blaner, T. M. Vanni, M. Moukides, and R. Ramakrishnan. 1990. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. J Clin. Invest. 86: 463-473.
39. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1991. Increased apoA-I and apoA-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87: 536-544.
40. Clay, M. A., G. J. Hopkins, C. P. Ehnholm, and P. J. Barter. 1989. The rabbit as an animal model of hepatic lipase deficiency. Biochim. Biophys. Acta. 1002: 173-181.
41. Hayek, T., N. Azrolan, R. B. Verdery, A. Walsh, T. Chajek-Shaul, L. B. Agellon, A. R. Tall, and J. L. Breslow. 1993. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J. Clin. Invest. 92: 1143-1152.
42. 18th Annual Meeting of the European Lipoprotein Club. 1996. Reviewed by: A. F. H. Stalenheof, K. Aalto-Setala, V. W. Armstrong, P. Benlian, and A. Steinmetz. Arteriosclerosis, 16: 898-904.
43. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96: 2758-2767.